Šilhavý, J <br/><br/>
Rosuvastatin ameliorates inflammation, renal fat accumulation, and kidney injury in transgenic spontaneously hypertensive rats expressing human C-reactive protein.  [electronic resource] 

 -  Physiological research  2015 
 - 295-301 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1802-9973 
<br/><br/><label>Standard No.: </label>10.33549/physiolres.932797  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Kidney Injury--drug therapy<br/>Adiposity--drug effects<br/>Animals<br/>C-Reactive Protein--genetics<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Hypertension--drug therapy<br/>Inflammation--drug therapy<br/>Kidney--drug effects<br/>Male<br/>Rats<br/>Rats, Inbred SHR<br/>Rats, Transgenic<br/>Rosuvastatin Calcium--therapeutic use<br/>Treatment Outcome